サマリー

不眠症治療薬の世界市場 2023-2027
不眠症治療薬市場は2022-2027年に1億293万米ドル成長し、予測期間中のCAGRは5.49%で加速すると予測されます。この調査レポートは、不眠症治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、不眠症の有病率の増加、診断と治療における技術的進歩、医療費と保険適用の増加などが牽引しています。
Technavio社の不眠症治療薬市場は以下のように分類されます：
タイプ別
- 薬剤
- デバイス
流通チャネル別
- 処方薬
- 一般用医薬品
地域別
- 北米
- アジア
- 欧州
- その他の地域（ROW）
本調査では、今後数年間の不眠症治療薬市場の成長を促進する主な理由の1つとして、非薬物療法への注目の高まりを挙げています。また、睡眠モニタリングやトラッキングの技術的進歩、メンタルヘルスの重要性に対する認識や受容の高まりは、市場の大きな需要につながるでしょう。
当レポートでは、不眠症治療薬市場について以下の分野をカバーしています：
- 不眠症治療薬市場の規模
- 不眠症治療薬市場の予測
- 不眠症治療薬市場の産業分析
本レポートでは、不眠症治療薬市場の主要ベンダー（Abbott Laboratories、Astellas Pharma Inc.、Aurobindo Pharma Ltd.、エーザイ株式会社、Electromedical Products, Inc.Ltd.、Electromedical Products International Inc.、Idorsia Pharmaceuticals Ltd.、INNOVATIVE NEUROLOGICAL DEVICES LLC、Mallinckrodt Plc、MEDICE Arzneimittel Putter GmbH and Co.KG、Merck and Co.Inc.、Minerva Neurosciences Inc.、Neurim Pharmaceuticals Ltd.、Pfizer Inc.、Questex LLC、Sanofi、Sumitomo Pharma Co.Ltd.、Vanda Pharmaceuticals Inc.、Viatris Inc.などである。また、不眠症治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/insomnia-therapeutics-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global insomnia therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size €“ Data Table on global insomnia therapeutics market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size €“ Distribution channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Drug - Market size and forecast 2022-2027
o Exhibit 34: Chart on Drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Drug - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Drug - Year-over-year growth 2022-2027 (%)
o 6.4 Devices - Market size and forecast 2022-2027
o Exhibit 38: Chart on Devices - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Devices - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Devices - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Devices - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Prescription - Market size and forecast 2022-2027
o Exhibit 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
o 7.4 OTC - Market size and forecast 2022-2027
o Exhibit 52: Chart on OTC - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on OTC - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on OTC - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Asia - Market size and forecast 2022-2027
o Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 Japan - Market size and forecast 2022-2027
o Exhibit 87: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 91: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Astellas Pharma Inc.
o Exhibit 107: Astellas Pharma Inc. - Overview
o Exhibit 108: Astellas Pharma Inc. - Product / Service
o Exhibit 109: Astellas Pharma Inc. - Key news
o Exhibit 110: Astellas Pharma Inc. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 111: Aurobindo Pharma Ltd. - Overview
o Exhibit 112: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 113: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Eisai Co. Ltd.
o Exhibit 114: Eisai Co. Ltd. - Overview
o Exhibit 115: Eisai Co. Ltd. - Business segments
o Exhibit 116: Eisai Co. Ltd. - Key offerings
o Exhibit 117: Eisai Co. Ltd. - Segment focus
o 12.6 Electromedical Products International Inc.
o Exhibit 118: Electromedical Products International Inc. - Overview
o Exhibit 119: Electromedical Products International Inc. - Product / Service
o Exhibit 120: Electromedical Products International Inc. - Key offerings
o 12.7 Idorsia Pharmaceuticals Ltd.
o Exhibit 121: Idorsia Pharmaceuticals Ltd. - Overview
o Exhibit 122: Idorsia Pharmaceuticals Ltd. - Product / Service
o Exhibit 123: Idorsia Pharmaceuticals Ltd. - Key offerings
o 12.8 INNOVATIVE NEUROLOGICAL DEVICES LLC
o Exhibit 124: INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
o Exhibit 125: INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
o Exhibit 126: INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
o 12.9 Merck and Co. Inc.
o Exhibit 127: Merck and Co. Inc. - Overview
o Exhibit 128: Merck and Co. Inc. - Business segments
o Exhibit 129: Merck and Co. Inc. - Key news
o Exhibit 130: Merck and Co. Inc. - Key offerings
o Exhibit 131: Merck and Co. Inc. - Segment focus
o 12.10 Minerva Neurosciences Inc.
o Exhibit 132: Minerva Neurosciences Inc. - Overview
o Exhibit 133: Minerva Neurosciences Inc. - Product / Service
o Exhibit 134: Minerva Neurosciences Inc. - Key offerings
o 12.11 Neurim Pharmaceuticals Ltd.
o Exhibit 135: Neurim Pharmaceuticals Ltd. - Overview
o Exhibit 136: Neurim Pharmaceuticals Ltd. - Product / Service
o Exhibit 137: Neurim Pharmaceuticals Ltd. - Key offerings
o 12.12 Pfizer Inc.
o Exhibit 138: Pfizer Inc. - Overview
o Exhibit 139: Pfizer Inc. - Product / Service
o Exhibit 140: Pfizer Inc. - Key news
o Exhibit 141: Pfizer Inc. - Key offerings
o 12.13 Sanofi
o Exhibit 142: Sanofi - Overview
o Exhibit 143: Sanofi - Business segments
o Exhibit 144: Sanofi - Key news
o Exhibit 145: Sanofi - Key offerings
o Exhibit 146: Sanofi - Segment focus
o 12.14 Sumitomo Pharma Co. Ltd.
o Exhibit 147: Sumitomo Pharma Co. Ltd. - Overview
o Exhibit 148: Sumitomo Pharma Co. Ltd. - Business segments
o Exhibit 149: Sumitomo Pharma Co. Ltd. - Key offerings
o Exhibit 150: Sumitomo Pharma Co. Ltd. - Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 151: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 152: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 153: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 154: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Vanda Pharmaceuticals Inc.
o Exhibit 158: Vanda Pharmaceuticals Inc. - Overview
o Exhibit 159: Vanda Pharmaceuticals Inc. - Product / Service
o Exhibit 160: Vanda Pharmaceuticals Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 161: Inclusions checklist
o Exhibit 162: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 163: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 164: Research methodology
o Exhibit 165: Validation techniques employed for market sizing
o Exhibit 166: Information sources
o 13.5 List of abbreviations
o Exhibit 167: List of abbreviations


Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global insomnia therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size €“ Distribution channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Drug - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Drug - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Drug - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Drug - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Devices - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Devices - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Devices - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Devices - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on OTC - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on OTC - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on OTC - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Astellas Pharma Inc. - Overview
Exhibits108: Astellas Pharma Inc. - Product / Service
Exhibits109: Astellas Pharma Inc. - Key news
Exhibits110: Astellas Pharma Inc. - Key offerings
Exhibits111: Aurobindo Pharma Ltd. - Overview
Exhibits112: Aurobindo Pharma Ltd. - Product / Service
Exhibits113: Aurobindo Pharma Ltd. - Key offerings
Exhibits114: Eisai Co. Ltd. - Overview
Exhibits115: Eisai Co. Ltd. - Business segments
Exhibits116: Eisai Co. Ltd. - Key offerings
Exhibits117: Eisai Co. Ltd. - Segment focus
Exhibits118: Electromedical Products International Inc. - Overview
Exhibits119: Electromedical Products International Inc. - Product / Service
Exhibits120: Electromedical Products International Inc. - Key offerings
Exhibits121: Idorsia Pharmaceuticals Ltd. - Overview
Exhibits122: Idorsia Pharmaceuticals Ltd. - Product / Service
Exhibits123: Idorsia Pharmaceuticals Ltd. - Key offerings
Exhibits124: INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
Exhibits125: INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
Exhibits126: INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
Exhibits127: Merck and Co. Inc. - Overview
Exhibits128: Merck and Co. Inc. - Business segments
Exhibits129: Merck and Co. Inc. - Key news
Exhibits130: Merck and Co. Inc. - Key offerings
Exhibits131: Merck and Co. Inc. - Segment focus
Exhibits132: Minerva Neurosciences Inc. - Overview
Exhibits133: Minerva Neurosciences Inc. - Product / Service
Exhibits134: Minerva Neurosciences Inc. - Key offerings
Exhibits135: Neurim Pharmaceuticals Ltd. - Overview
Exhibits136: Neurim Pharmaceuticals Ltd. - Product / Service
Exhibits137: Neurim Pharmaceuticals Ltd. - Key offerings
Exhibits138: Pfizer Inc. - Overview
Exhibits139: Pfizer Inc. - Product / Service
Exhibits140: Pfizer Inc. - Key news
Exhibits141: Pfizer Inc. - Key offerings
Exhibits142: Sanofi - Overview
Exhibits143: Sanofi - Business segments
Exhibits144: Sanofi - Key news
Exhibits145: Sanofi - Key offerings
Exhibits146: Sanofi - Segment focus
Exhibits147: Sumitomo Pharma Co. Ltd. - Overview
Exhibits148: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits149: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits150: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits151: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits152: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits153: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits154: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits155: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits156: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits158: Vanda Pharmaceuticals Inc. - Overview
Exhibits159: Vanda Pharmaceuticals Inc. - Product / Service
Exhibits160: Vanda Pharmaceuticals Inc. - Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Validation techniques employed for market sizing
Exhibits166: Information sources
Exhibits167: List of abbreviations